Cardiac Sarcoplasmic Reticulum Calcium Cycling Proteins
Cardiac Sarcoplasmic Reticulum Calcium Cycling Proteins
批准号:
7367840
负责人:
Evangelia G Kranias
金额:
$36.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2010-01-31
关键词:
ATP phosphohydrolaseATP2A2AcuteAdultAgonistAnimal ModelAnimalsBindingBinding ProteinsBiochemicalBiological ModelsBuffersCalciumCalsequestrinCardiacCardiac MyocytesChronicComplementConditionCytosolDepressed moodDiseaseFunctional disorderGoalsHealthHeartHeart ContractilitiesHeart DiseasesHeart HypertrophyHeart failureHistidineHomeostasisHumanHypertrophyKnowledgeLeadModelingMolecularMusMuscle ContractionMuscle relaxation phaseMyocardiumOrganPhasePhenotypePhosphoric Monoester HydrolasesPhosphorylationPhysiologicalPhysiologyPlayProcessPropertyProtein OverexpressionProteinsRegulationResearchRoleRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumStagingStimulusStressSystemTimebaseimprovedin vivoin vivo Modelinhibitor/antagonistinsightmouse junctate proteinphospholambanpressureprogramsprotein phosphatase inhibitor-1responsetriadinuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The depressed Ca-cycling in animal models of heart failure and human failing hearts has been suggested to reflect, at least in part, the impaired Ca-cycling by the sarcoplasmic reticulum (SR). There are three major functions of the SR: a) Ca-uptake from the cytosol into the SR lumen resulting in muscle relaxation; b) Ca-storage in the SR lumen; and c) Ca-release from the SR into the cytosol resulting in muscle contraction. The main SR proteins responsible for these functions are: the Ca-transport ATPase (SERCA2) with its regulator phospholamban (PLN); the Ca-storage proteins, calsequestrin and a histidine rich Ca-binding protein (HRC); and the Ca-release ensemble composed of the ryanodine receptor, junctin and triadin. In this project, we propose further studies on elucidating the regulatory role of increased (chronic or acute) PLN phosphorylation, through regulation of its phosphatase 1 activity by Inhibitor-I, in the control of contractility and the heart's responses to stress. Furthermore, since alterations in the degree of PLN phosphorylation reflect alterations in SR Ca-load and release, we propose to elucidate the functional roles of: a) SR Ca load through calsequestrin, the major Ca storage protein in the SR lumen; and b) SR Ca-release through junctin, one of the major proteins in the release cassette. Animal models with reduced or ablated expression of calsequestrin or junctin will be generated and their cardiac phenotypes will be analyzed at the molecular, subcellular, cellular, organ and intact animal levels under basal and stress conditions. These studies will provide important information on the functional role of calsequestrin and junctin in vivo under physiological and pathophysiological conditions. Overall, our proposed studies will advance our knowledge on the mechanisms underlying regulation of Ca homeostasis by the SR function in the mammalian heart. They will also provide valuable insights into the crosstalk between the various SR Ca handling proteins and their regulatory effects on cardiac contractility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding Cardiovascular Disease Mechanisms
-
批准号:10421306
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Understanding Cardiovascular Disease Mechanisms
-
批准号:10176556
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Understanding Cardiovascular Disease Mechanisms
-
批准号:8969700
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Understanding Cardiovascular Disease Mechanisms
-
批准号:10009722
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Understanding Cardiovascular Disease Mechanisms
-
批准号:10640285
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Understanding Cardiovascular Disease Mechanisms
-
批准号:8793244
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2014
-
负责人:Evangelia G Kranias
-
依托单位:
Calcium Cycling Protein Mutations in Human Heart Failure
-
批准号:7338017
-
项目类别:
-
资助金额:$49.17万
-
财政年份:2007
-
负责人:Evangelia G Kranias
-
依托单位:
Calcium Cycling Protein Mutations in Human Heart Failure
-
批准号:7312576
-
项目类别:
-
资助金额:$48.55万
-
财政年份:2006
-
负责人:Evangelia G Kranias
-
依托单位:
Calcium Cycling Protein Mutations in Human Heart Failure
-
批准号:6892776
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2005
-
负责人:Evangelia G Kranias
-
依托单位:
Genetic and Molecular Signaling in Heart Failure
-
批准号:7564000
-
项目类别:
-
资助金额:$395.87万
-
财政年份:2005
-
负责人:Evangelia G Kranias
-
依托单位:
Genetic and Molecular Signaling in Heart Failure
-
批准号:7338024
-
项目类别:
-
资助金额:$378.09万
-
财政年份:2005
-
负责人:Evangelia G Kranias
-
依托单位:
The Role of Phospholamban in Ischemia: Transgenic Appro*
-
批准号:6740936
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2003
-
负责人:Evangelia G Kranias
-
依托单位:
The Role of Phospholamban in Ischemia: Transgenic Appro*
-
批准号:6641396
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2003
-
负责人:Evangelia G Kranias
-
依托单位:
The Role of Phospholamban in Ischemia: Transgenic Appro*
-
批准号:6886790
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2003
-
负责人:Evangelia G Kranias
-
依托单位:
SARCOPLASMIC RETICULUM FUNCTION IN NORMAL AND FAILING HEARTS
-
批准号:6564931
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2002
-
负责人:Evangelia G Kranias
-
依托单位:
SARCOPLASMIC RETICULUM FUNCTION IN NORMAL AND FAILING HEARTS
-
批准号:6419408
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2001
-
负责人:Evangelia G Kranias
-
依托单位:
CARDIAC SARCOPLASMIC RETICULIM CALCIUM CYCLING PROTEINS
-
批准号:6039092
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2000
-
负责人:Evangelia G Kranias
-
依托单位:
Cardiac Sarcoplasmic Reticulum Calcium Cycling Proteins
-
批准号:8989140
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2000
-
负责人:Evangelia G Kranias
-
依托单位:
CARDIAC SARCOPLASMIC RETICULIM CALCIUM CYCLING PROTEINS
-
批准号:6351606
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2000
-
负责人:Evangelia G Kranias
-
依托单位:
Cardiac Sarcoplasmic Reticulum Calcium Cycling Proteins
-
批准号:6872511
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2000
-
负责人:Evangelia G Kranias
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TMEM8B-a 多聚化修饰降解 ATP2A2 蛋白抑制肺癌细胞集体侵袭的分子机制及靶向抑制剂转化应用研究
-
批准号:2022JJ10096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:王理
-
依托单位:
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
-
批准号:82241015
-
项目类别:专项项目
-
资助金额:50.00万元
-
批准年份:2022
-
负责人:缪冉
-
依托单位:
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
-
批准号:82172879
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:王理
-
依托单位:
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
-
批准号:81771408
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2017
-
负责人:尹飞
-
依托单位: